首页> 外文期刊>Journal of biomedical materials research, Part A >Porous Gelatin-Chondroitin-Hyaluronate Tri-Copolymer Scaffold Containing Microspheres Loaded With TGF-beta 1 Induces Differentiation of Mesenchymal Stem Cells In Vivo For Enhancing Cartilage Repair
【24h】

Porous Gelatin-Chondroitin-Hyaluronate Tri-Copolymer Scaffold Containing Microspheres Loaded With TGF-beta 1 Induces Differentiation of Mesenchymal Stem Cells In Vivo For Enhancing Cartilage Repair

机译:多孔微明胶软骨素-透明质酸三共聚物支架包含微球与TGF-β1加载诱导分化的间充质干细胞体内增强软骨修复。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the study was to produce a novel porous gelatin-chondroitin-hyaluronate scaffold in combination with a controlled release of transforming growth factor beta 1 (TGF- beta l), which induced the differentiation of mesenchymal stem cells (MSCs) in vivo for enhancing cartilage repair. Gelatin microspheres loaded with TGF-beta 1 (MS-TGF beta 1) showed a fast release at the initial phase (37.4 percent), and the ultimate accumulated release was 83.1 percent by day 18. The autologous MSCs seeded on MS-TGF beta 1/scaffold were implanted to repair full-thickness cartilage defects in rabbits as in vivo differentiation repair group, while MSCs differentiated in vitro were seeded on scaffold without MS-TGF(31 to repair the contra lateral cartilage defects (n = 30). Fifteen additional rabbits without treatment for defects were used as control. Histology observation showed that the in vivo differentiation repair group had better chondrocyte morphology, integration, continuous subchondral bone, and much thicker newly formed cartilage layer when compared to in vitro differentiation repair group 12 and 24 weeks, postoperatively. There was a significant difference in histo-logical grading score between these two experimental groups, and both showed much better repair than that of the control. The present study implied that the novel scaffold with MS-TGF beta 1 might serve as a new way to induce the differentiation of MSCs in vivo to enhance the cartilage repair.
机译:该研究的目的是结合控制释放的转化生长因子β1(TGF-β1)来生产新型多孔明胶-软骨素-透明质酸盐支架,该支架可诱导体内间充质干细胞(MSCs)分化。加强软骨修复。载有TGF-beta 1(MS-TGF beta 1)的明胶微球在初始阶段显示快速释放(37.4%),到18天最终累积释放为83.1%。接种在MS-TGF beta 1上的自体MSC /支架作为体内分化修复组植入兔全层软骨缺损修复,而体外分化的MSCs植入无MS-TGF的支架上(31修复对侧软骨缺损(n = 30),另外15个)组织学观察发现,与体外分化修复组相比,体内分化修复组的软骨细胞形态,整合,软骨下骨连续性好,且新形成的软骨层厚得多。这两个实验组之间的组织学分级得分存在显着差异,并且两者的修复效果均优于对照组。控制。本研究表明,具有MS-TGFβ1的新型支架可能作为诱导MSCs体内分化以增强软骨修复的新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号